Nisidinasol (Paracetamol)

Paracetamol, the active ingredient in Nisidinasol, is an analgesic presented as an oral dosage form for oral use. It is commonly employed to reduce fever and relieve mild to moderate pain in adults and children when appropriate dosing is applied, and is available over‑the‑counter in many European markets.

GNH USA supplies Nisidinasol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Nisidinasol, a paracetamol‑based analgesic, acts on the prostaglandin pathway to manage common pain and fever conditions. - Fever: helps lower elevated body temperature. - Headache: provides relief from tension‑type headaches. - Musculoskeletal pain: alleviates mild to moderate aches and strains. - Toothache: reduces pain associated with dental discomfort.

Paracetamol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset. - Abdominal discomfort: transient discomfort in the upper abdomen. - Rash: mild skin redness or itching. - Dizziness: occasional light‑headed sensation.

Serious or Rare Side Effects: - Hepatotoxicity: potential liver injury, especially with overdose. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Blood disorders: rare cases of thrombocytopenia or leukopenia. - Anaphylaxis: immediate hypersensitivity reaction requiring emergency care.

When using Nisidinasol, consider the following safety measures. - Dosage adjustment: reduce dose in patients with hepatic impairment. - Avoid alcohol: concurrent consumption may increase liver toxicity risk. - Allergy: do not use if hypersensitive to paracetamol or related compounds. - Pregnancy: consult a healthcare professional before use. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Paracetamol may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Alcohol: heightened risk of liver injury. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk. - Isoniazid: combined use can raise hepatotoxicity potential.

Moderate Interactions (Monitor Closely): - Carbamazepine: may reduce paracetamol efficacy. - Phenobarbital: may increase paracetamol metabolism. - Phenytoin: may accelerate paracetamol clearance, lowering therapeutic levels.